Euroapi SAS
PAR:EAPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PXP Energy Corp
XPHS:PXP
|
PH |
|
T
|
Tri Viet Securities JSC
VN:TVB
|
VN |
|
Storskogen Group AB (publ)
STO:STOR B
|
SE |
Euroapi SAS
Cash from Operating Activities
Euroapi SAS
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Euroapi SAS
PAR:EAPI
|
Cash from Operating Activities
€128.6m
|
CAGR 3-Years
42%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Sanofi SA
PAR:SAN
|
Cash from Operating Activities
€10.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
|
Ipsen SA
PAR:IPN
|
Cash from Operating Activities
€1.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
18%
|
|
|
Vetoquinol SA
PAR:VETO
|
Cash from Operating Activities
€71.4m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
7%
|
|
|
Virbac SA
PAR:VIRP
|
Cash from Operating Activities
€199m
|
CAGR 3-Years
26%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
Medincell SA
PAR:MEDCL
|
Cash from Operating Activities
-€16.9m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's Cash from Operating Activities?
Cash from Operating Activities
128.6m
EUR
Based on the financial report for Dec 31, 2025, Euroapi SAS's Cash from Operating Activities amounts to 128.6m EUR.
What is Euroapi SAS's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
6%
Over the last year, the Cash from Operating Activities growth was 5%. The average annual Cash from Operating Activities growth rates for Euroapi SAS have been 42% over the past three years , 6% over the past five years .
